A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

Clinical trial NCT05518149 · TERMINATED

Trial details

NCT number: NCT05518149
Sponsor: Janssen Research & Development, LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2022-09-22
Primary completion: 2025-04-25
Enrollment: 871

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.